Rumors of Pfizer bid boost Bayer...again

Will rumors of a Pfizer bid for Bayer ever die? The talk boosted Bayer's stock in Frankfurt earlier today, despite the bankers who've persistently pooh-poohed the idea. Where there's smoke there's fire, perhaps--or maybe traders just like to talk. Report

Suggested Articles

AstraZeneca
Marketing

AZ's Calquence steps up to challenge Imbruvica with big CLL nod

Imbruvica has enjoyed a nice run in previously untreated CLL over the last few years. But major competition is here in the form of AZ's Calquence.

by Carly Helfand, by Angus Liu
jnj
Pharma

J&J's Risperdal caseload explodes with Pennsylvania ruling

Pennsylvania's Supreme Court revived thousands of lawsuits alleging the antipsychotic med Risperdal caused males to develop breasts.

by Eric Sagonowsky
Black-and-white image of a thumbs-up hand and a thumbs-down hand in front of a blank wall.
Marketing

Which asthma biologic is the most popular of them all?

In the asthma biologics race, there doesn't appear to be a clear favorite among Xolair, Dupixent, Fasenra and Nucala for a group of pulmonologists.

by Angus Liu